The total return over the past 12 months is -39.70% vs. +16.94% for the S&P 500. So far it's up -37.88% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (39.70%) | +14.35% | +5.06% | N/A | N/A | N/A |
| Total Return CAGR | (39.70%) | +14.35% | +5.06% | N/A | N/A | N/A |
| Revenue CAGR | +17.76% | +20.54% | +18.21% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | +21.21% | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (6.32%) | +34.67% | +19.55% | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (5.03%) | +33.53% | +19.58% | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Cellebrite DI Ltd. (CLBT)
| Year | Start price | End price | CLBT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $18.03 | $11.20 | (37.88%) | +14.51% | (52.39%) |
| 2025 | $22.03 | $18.03 | (18.16%) | +17.72% | (35.88%) |
| 2024 | $8.66 | $22.03 | +154.39% | +24.89% | +129.50% |
| 2023 | $4.36 | $8.66 | +98.62% | +26.19% | +72.43% |
| 2022 | $8.02 | $4.36 | (45.64%) | (18.17%) | (27.47%) |
| 2021 | $10.53 | $8.02 | (23.84%) | +28.74% | (52.58%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
